Global Neurostimulation Market exhibited a value of USD 5,716.5 million in 2017

Global Neurostimulation Market exhibited a value of USD 5,716.5 million in 2017

Growing demand for safer, more efficient, minimally invasive and more cost-effective procedures for neurological disorders are expected to are expected to drive the adoption rates of neurostimulation devices in the coming years – GMI Research

The global neurostimulation market exhibited a value of USD 5,716.5 million in 2017 and is projected to reach USD 14,476.4 million by 2025, growing at a CAGR of 12.6% during 2018–2025 on account of factors, such as growing prevalence of diseases treatable with neurostimulation, increasing R&D activities for the development of innovative neurostimulation products coupled with rising awareness and high unmet medical needs.

Request Sample Pages : https://tinyurl.com/ya87rn7f

Neurostimulation is gaining traction over conventional pain management procedures due to minimally invasive nature of the surgeries and huge investments for the development of novel technologies that can help in improving healthcare systems for patients.

The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson’s disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advancement in neural stimulation technology in combination with a deeper understanding of the nervous system are also likely to drive the market growth during the forecast period.

Implantable spinal cord stimulator segment held the largest revenue share in 2017 and is expected to exhibit significant revenue share during the forecast period owing to increasing number of people suffering from chronic pain and rising awareness about spinal cord stimulator. Introduction of advanced technologies and products, such as adaptiveStim technology, neurowave medical technologies, MRI safety incorporated devices and rechargeable spinal cord stimulators are likely to aid the market growth in the coming years.

Hospital segment captured the largest share in 2017 and is predicted to grow at a CAGR 13.1% during the forecast period owing to rising patient emphasis on timely and effective pain management and increasing number of hospitals and neurology clinics in developing countries. Also, significant healthcare spending and increasing government & private investments for healthcare facilities infrastructure are expected to boost the growth of global neurostimulation market during the forecast period.

“Major companies are focussing on research & development activities in order to develop innovative neurostimulation devices that are technologically advanced and are more efficient. The introduction of next-generation Senza II spinal cord stimulation system, portable neuromodulation stimulator (PoNS™) device and MRI safety incorporated devices in the market are expected to boost the demand during the forecast period.” —-GMI Research

Buy Report @ https://tinyurl.com/ya87rn7f

Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of neurostimulation procedures in the region. In 2017, Europe registered a significant growth rate in global neurostimulation market. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to exhibit a CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc.

Key takeaways:
•    The implantable spinal cord stimulator product type segment is expected to grow by 2.4X by 2025 compared to 2017.
•    The companies are focussing on research and development activities through strategic research collaborations. For instance, in August 2018, ElectroCore, Inc. and Massachusetts General Hospital collaborated for research on Non-Invasive Vagus Nerve Stimulation.
•    Boston Scientific Corporation, Medtronic plc, Abbott laboratories, Nevro Corp are the leading players holding the maximum market share.

Some of the key players operating in global neurostimulation market include Boston Scientific Corporation, Medtronic plc, Cyberonics Inc., Nevro Corp, NeuroPace, Inc., Depuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL. among others.

The global neurostimulation market has been segmented on the basis of product type, indication type, end users and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non-implantable. Wherein, implantable segment includes deep brain stimulators, sacral nerve stimulator, spinal cord stimulators, vagus nerve stimulators and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS).

Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy and others.

Based on end user, the market has been segmented into hospitals, ambulatory surgical centers and specialty clinics.

The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market across the globe, based on product type, indication, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-neurostimulation-market-product-type-indication-end-user-opportunities-forecast-share-trends-industry-analysis.html
Early buyers will get customization upto 20% on report

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Advertisements
North America to continue to lead the anti-epileptic drugs market – GMI Research

North America to continue to lead the anti-epileptic drugs market – GMI Research

The global Anti-Epileptic Drugs market was valued at USD 3,323.7 million in 2017 and is projected to reach USD 4,458.1 million by 2025, growing at a CAGR of 3.8% during 2018–2025. The major factors driving the anti-epileptic drugs market is the rising awareness about epilepsy, new drug approvals, and drug structure advancements in Anti-Epileptic Drugs industry are likely to drive the growth of the global Anti-Epileptic Drugs market in near future.

Furthermore, advancements in medication management and healthcare services with the increasing number of drug approvals across the globe have led to the burgeoning market growth of Anti-Epileptic Drugs market.

Request Sample Brochure  : https://tinyurl.com/y776x8ar

Valproic Acid drug segment is expected to dominate global Anti-Epileptic Drugs market during the forecast period. In 2017, about one-fourth of the market share was held by Valproic Acid drug in the component segment. However, the highest growth rate is expected to be witnessed by the Lacosamide component segment during the forecast period owing to the increase in usage in the treatment of partial-onset seizures.

“Players are investing a lot in developing and introducing anti-epileptic drugs. For instance, On January 2017, Novartis drug Votubia got approval from EU. This drug will be used for the treatment of refractory partial-onset seizures in patients with TSC. Further, it is foreseen with the growing awareness about the disease and government initiatives the anti-epileptic drugs market will witness significant growth in the emerging markets of Asia-Pacific in the coming 4-5 years .”
—-GMI Research

Based on geography, North America held the largest share in the market in 2017 because of growing awareness about the disease and treatment available, increasing number of rehabs and surgical centers in the region and exponential increase in the epilepsy population. In addition, there has been a rise in the number of approved anti- epileptic drugs. Europe is the second largest region for Anti-Epileptic Drugs market and is expected to grow at a moderate rate during the forecast period.

Buy Report @ https://tinyurl.com/y776x8ar

Key takeaways:
•    In 2017, the Valproic Acid drug type held about one-fourth of the market share.
•    Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, and Valeant Pharmaceuticals are the leading players.
•    Lacosamide drug type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    North America region occupied maximum revenue share in the global Anti-Epileptic Drugs market in 2017.

Some of the key players operating in global Anti-Epileptic Drugs market include Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi S.A, UCB Pharma Ltd, GlaxoSmithKline plc, Johnson & Johnson, Novartis, AG, Pfizer Inc among others.

The global Anti-Epileptic Drugs market has been segmented on the basis of spectrum type, the market comprises of Narrow and Broad Spectrum. The drug type includes Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide.

The research report “global Anti-Epileptic Drugs market” provides in-depth analysis of the Anti-Epileptic Drugs market, globally, based on spectrum type, drug type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Anti-Epileptic Drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-anti-epileptic-drugs-market-opportunities-forecast-by-spectrum-type-share-trends-industry-report.html

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Global Neurostimulation Market Opportunities & Forecast (2018-2025)-GMI Research

Global Neurostimulation Market Opportunities & Forecast (2018-2025)-GMI Research

Global Neurostimulation Market by Product Type (Implantable {Deep Brain Stimulators, Sacral Nerve Stimulator, Spinal Cord Stimulators, Vagus Nerve Stimulators and Others} and Non-implantable {Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS)}), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and by Geography – Opportunities & Forecast, 2018-2025

The global neurostimulation market was valued at USD 5,716.5 million in 2017, and is projected to reach USD 14,476.4 million by the end of 2025, growing at a CAGR of 12.6% during 2018–2025.

Figure 1: Global Neurostimulation Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

Request Sample Pages : https://tinyurl.com/ya87rn7f

The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson’s disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advances in neural stimulation technology in combination with a deeper understanding of the nervous system are also expected to aid the market growth.

Based on product type, implantable spinal cord stimulators segment is anticipated to lead the market during 2018–2025

Implantable spinal cord stimulators product type segment is expected to dominate the market during the forecast period due to an increase in clinical trials for the treatment of new indications. Moreover, the adoption of spinal cord stimulators is high as compared to conventional treatments as spinal cord stimulation procedure is minimally invasive, provides quicker recovery and is cost-effective.

The chronic pain by indication segment held the largest share in 2017 in the market, and is predicted to exhibit a significant growth rate during the forecast period owing to rising patients’ emphasis on timely and effective pain management and increase in prevalence of chronic pain disorder, globally. For instance, according to the American Academy of Pain Medicine, in 2011, more than 100.0 million people were affected by the chronic pain in the United States. Also, extensive research and development activities and the introduction of advanced neurostimulation products are predicted to aid the market growth in the coming years.

Players, such as Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., and Nevro Corp are focusing on R&D activities to expand their product portfolio.


Figure 2: Global Neurostimulation Market Revenue, by Region, 2017

Source: GMI Research

Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of neurostimulation procedures in the region. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to grow at CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc.

Various notable players operating in the market include Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., Nevro Corp, NeuroPace, Inc., DePuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL., among others.

The global neurostimulation market has been segmented on the basis of product type, indication, end user, and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non-implantable. Wherein, the implantable segment includes deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics.

The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market, globally, based on product type, indication, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fueling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is neurostimulation market growing, globally? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the neurostimulation market?
4-    What are the various application areas and how they are poised to grow?

For Sample Pages & Detailed Report Description Click  @  https://www.gmiresearch.com/report/global-neurostimulation-market-product-type-indication-end-user-opportunities-forecast-share-trends-industry-analysis.html

Table of Contents (TOC)

1.    Executive Summary

2.    Introduction  
2.1.    Study Objectives
2.2.    Market Definition
2.2.1.     Market Covered
2.2.2.    Geographical Coverage
2.2.3.    Study Years & Currency
2.3.    Market Stakeholders
2.4.    Key Questions this Study will Answer
2.5.    GMI Research’s Approach & Methodology
3.    Global Neurostimulation Market – Overview
3.1.    Introduction         `
3.2.    Market Segmentation
3.3.    Value Chain Analysis
3.4.    Drivers
3.5.    Restraints
3.6.    Trends
4.    Global Neurostimulation Market Revenue Forecast till 2025

5.    Global Neurostimulation Market by Product Type Revenue Forecast till 2025
5.1.    Implantable
5.1.1.    Deep Brain Stimulators
5.1.2.    Sacral Nerve Stimulator
5.1.3.    Spinal Cord Stimulators
5.1.4.    Vagus Nerve Stimulators
5.1.5.    Others
5.2.    Non-implantable
5.2.1.    Transcranial Magnetic Stimulation (TMS)
5.2.2.    Transcutaneous Electrical Nerve stimulation (TENS)
6.    Global Neurostimulation Market by Indication Revenue Forecast till 2025   
6.1.    Chronic pain
6.2.    Movement disorders
6.3.    Epilepsy
6.4.    Others
7.    Global Neurostimulation Market by End User Revenue Forecast till 2025
7.1.    Hospitals
7.2.    Ambulatory Surgical Centers
7.3.    Specialty Clinics
8.    Global Neurostimulation Market by Geography Revenue Forecast till 2025
8.1.    North America Neurostimulation Market Revenue Forecast till 2025
8.1.1.    North America Neurostimulation Market by Product Type (Option 1: 25% customization)
8.1.1.1.    Implantable
8.1.1.1.1.    Deep Brain Stimulators
8.1.1.1.2.    Sacral Nerve Stimulator
8.1.1.1.3.    Spinal Cord Stimulators
8.1.1.1.4.    Vagus Nerve Stimulators
8.1.1.1.5.    Others

8.1.1.2.    Non-implantable
8.1.1.2.1.    Transcranial Magnetic Stimulation (TMS)
8.1.1.2.2.    Transcutaneous Electrical Nerve stimulation (TENS)

8.1.2.    North America Neurostimulation Market by Indication
8.1.2.1.    Chronic pain
8.1.2.2.    Movement disorders
8.1.2.3.    Epilepsy
8.1.2.4.    Others

8.1.3.    North America Neurostimulation Market by End User
8.1.3.1.    Hospitals
8.1.3.2.    Ambulatory Surgical Centers
8.1.3.3.    Specialty Clinics

8.2.    Europe Neurostimulation Market Revenue Forecast till 2025
8.2.1.    Europe Neurostimulation Market by Product Type (Option 2: 25% customization)
8.2.1.1.    Implantable
8.2.1.1.1.    Deep Brain Stimulators
8.2.1.1.2.    Sacral Nerve Stimulator
8.2.1.1.3.    Spinal Cord Stimulators
8.2.1.1.4.    Vagus Nerve Stimulators
8.2.1.1.5.    Others
8.2.1.2.    Non-implantable
8.2.1.2.1.    Transcranial Magnetic Stimulation (TMS)
8.2.1.2.2.    Transcutaneous Electrical Nerve stimulation (TENS)

8.2.2.    Europe Neurostimulation Market by Indication
8.2.2.1.    Chronic pain
8.2.2.2.    Movement disorders
8.2.2.3.    Epilepsy
8.2.2.4.    Others

8.2.3.    Europe Neurostimulation Market by End User
8.2.3.1.    Hospitals
8.2.3.2.    Ambulatory Surgical Centers
8.2.3.3.    Specialty Clinics

8.3.    Asia-Pacific Neurostimulation Market Revenue Forecast till 2025
8.3.1.    Asia-Pacific Neurostimulation Market by Product Type (Option 3: 25% customization)
8.3.1.1.    Implantable
8.3.1.1.1.    Deep Brain Stimulators
8.3.1.1.2.    Sacral Nerve Stimulator
8.3.1.1.3.    Spinal Cord Stimulators
8.3.1.1.4.    Vagus Nerve Stimulators
8.3.1.1.5.    Others

8.3.1.2.    Non-implantable
8.3.1.2.1.    Transcranial Magnetic Stimulation (TMS)
8.3.1.2.2.    Transcutaneous Electrical Nerve stimulation (TENS)

8.3.2.    Asia-Pacific Neurostimulation Market by Indication
8.3.2.1.    Chronic pain
8.3.2.2.    Movement disorders
8.3.2.3.    Epilepsy
8.3.2.4.    Others

8.3.3.    Asia-Pacific Neurostimulation Market by End User
8.3.3.1.    Hospitals
8.3.3.2.    Ambulatory Surgical Centers
8.3.3.3.    Specialty Clinics

8.4.    Rest of the World Neurostimulation Market Revenue Forecast till 2025
8.4.1.    Rest of the World Neurostimulation Market by Product Type (Option 4: 25% customization)
8.4.1.1.    Implantable
8.4.1.1.1.    Deep Brain Stimulators
8.4.1.1.2.    Sacral Nerve Stimulator
8.4.1.1.3.    Spinal Cord Stimulators
8.4.1.1.4.    Vagus Nerve Stimulators
8.4.1.1.5.    Others
8.4.1.2.    Non-implantable
8.4.1.2.1.    Transcranial Magnetic Stimulation (TMS)
8.4.1.2.2.    Transcutaneous Electrical Nerve stimulation (TENS)

8.4.2.    Rest of the World Neurostimulation Market by Indication
8.4.2.1.    Chronic pain
8.4.2.2.    Movement disorders
8.4.2.3.    Epilepsy
8.4.2.4.    Others

8.4.3.    Rest of the World Neurostimulation Market by End User
8.4.3.1.    Hospitals
8.4.3.2.    Ambulatory Surgical Centers
8.4.3.3.    Specialty Clinics

9.    Competitive Landscape 
9.1.    Porter 5 Analysis
9.2.    Major players and their key strategies
9.3.    Company Share Analysis

10.    Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
10.1.    Medtronic plc
10.1.1.    Company Overview
10.1.2.    Financials
10.1.3.    Recent Developments
10.2.    Cyberonics Inc.
10.2.1.    Company Overview
10.2.2.    Financials
10.2.3.    Recent Developments
10.3.    NeuroPace, Inc.
10.3.1.    Company Overview
10.3.2.    Financials
10.3.3.    Recent Developments
10.4.    NeuroSigma, Inc.
10.4.1.    Company Overview
10.4.2.    Financials
10.4.3.    Recent Developments
10.5.    Nevro Corp.
10.5.1.    Company Overview
10.5.2.    Financials
10.5.3.    Recent Developments
10.6.    Depuy Synthes
10.6.1.    Company Overview
10.6.2.    Financials
10.6.3.    Recent Developments
10.7.    Synapse Biomedical Inc.
10.7.1.    Company Overview
10.7.2.    Financials
10.7.3.    Recent Developments
10.8.    Boston Scientific Corporation
10.8.1.    Company Overview
10.8.2.    Financials
10.8.3.    Recent Developments
10.9.    Bayer Corporation
10.9.1.    Company Overview
10.9.2.    Financials
10.9.3.    Recent Developments
10.10.    BioControl Medical
10.10.1.    Company Overview
10.10.2.    Financials
10.10.3.    Recent Developments
11.    About GMI Research

Buy Report @ https://tinyurl.com/ya87rn7f

Related Report :

Global Behavioral Health Market by Services Type (Inpatient Hospital Treatment, Outpatient Counselling, Home-Based Treatment Services, Emergency Mental Health Services, and Intensive Care Management), By Disorder (Anxiety Disorder, Bipolar Disorder, Depression, Eating Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorder and Others) End-Users (Outpatient Clinics, Rehabilitation Centers, Hospitals (Emergency), Homecare Setting) and by Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

Global Orthopedic Prosthetics Market was valued at USD 2,759.6 million in 2017

Global Orthopedic Prosthetics Market was valued at USD 2,759.6 million in 2017

Electric powered technology held the largest revenue share in 2017, and is expected to dominate through 2025, growing at a CAGR of 5.3% during 2018-2025 – GMI Research

The global orthopedic prosthetics market was valued at USD 2,759.6 million in 2017, and is projected to reach USD 4,158.2 million by 2025, growing at a CAGR of 5.3% during 2018–2025. The key factors boosting growth of the market are increasing incidence of trauma/accidental injuries, innovations and technological advancement in orthopedic prosthetics technology and introduction of custom-made implant products.

Request Sample Brochure  : https://tinyurl.com/y7vso3qa

Furthermore, increasing adoption of orthopedic prosthetic products at prosthetic clinics, rising technological advancement and spending on healthcare facilities across the globe have led to burgeoning market growth of orthopedic prosthetics market.

Lower limb product type segment is expected to dominate global orthopedic prosthetics market during the forecast period. In 2017, more than half of the market share was held by the lower limb segment. However, the highest growth rate is expected to be witnessed by the upper limb segment during the forecast period owing to growing adoption of upper limb prosthetics among healthcare professionals and patients due to their characteristics of high stability and advanced properties.

Technological advancements in orthopedic prosthetics industry and increasing research & development activities are likely to drive the growth of global orthopedic prosthetics market in near future. Hybrid prosthetics technology in the orthopedic prosthetics market is the upcoming technology to look forward to.

“The companies are focussing on partnership with firms, mergers & acquisitions and investment in research & development activities to keep leadership in the competitive orthopedic prosthetics market. For example: On March, 2016, Zimmer Biomet announced the acquisition of Ortho Transmission and its technology, developed by a US military surgeon, which may improve mobility for amputees.”
—-GMI Research 

Buy Report @ https://tinyurl.com/y7vso3qa

Based on geography, North America held the largest share in the market in 2017 because of large adoption rate of orthopedic prosthetics, high volume of clinical procedures and growth in medical tourism. In addition, there has been a rise in incidence of trauma injuries. Asia-Pacific holds the third largest share in global orthopedic prosthetics market and is expected to grow at a moderate rate during the forecast period.

Key takeaways/key essentials:
•    In 2017, the prosthetic clinics end user type held more than three forth of the market share.
•    Biomet Inc., Johnson & Johnson, and Stryker Corp. are the leading players holding approximately around one third of the market share.
•    The hybrid prosthetics technology type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    Hybrid prosthetics is the emerging prosthetic technology in the orthopedic prosthetics field, which is intended to cater to the unmet needs of the prosthetic market.
•    North America region occupied maximum revenue share in global orthopedic prosthetics market in 2017.

Some of the key players operating in global orthopedic prosthetics market include, Smith and Nephew plc, Biomet Inc., Johnson & Johnson, Stryker Corp., Otto Bock HealthCare GmbH, Blatchford Ltd, Touch Bionics Inc., Hanger Inc., Fillauer LLC and The Ohio Willow Wood Co.

The global orthopedic prosthetics market has been segmented on the basis of product type, technology type, end user type and key geographies. Based on product type, the market comprises of upper limb, lower limb and others (sockets, fingers, etc).

The technology type comprises of conventional, electric powered and hybrid prosthetics. The end user type comprises of prosthetic clinics, hospitals, rehabilitation centers and others (ASCs, normal clinics, etc).

The research report “global orthopedic prosthetics market” provides in-depth analysis of orthopedic prosthetics market, globally, based on product type, technology type, end user type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for orthopedic prosthetics market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-orthopedic-prosthetics-market-opportunities-forecast-by-product-type-technology-end-user-share-trends-insights.html

Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com
Global Orthopedic Prosthetics Market Opportunities & Forecast (2018-2025)-GMI Research

Global Orthopedic Prosthetics Market Opportunities & Forecast (2018-2025)-GMI Research

Global Orthopedic Prosthetics Market, By Product Type (Upper Limb, Lower Limb and Others), By Technology Type (Conventional, Electric Powered and Hybrid Prosthetics), By End User Type (Hospitals, Prosthetic Clinics, Rehabilitation Centers, and Others), and Geography – Opportunities & Forecast, 2018-2025

The global orthopedic prosthetics market was valued at USD 2,759.6 million in 2017, and is projected to reach USD 4,158.2 million by 2025, growing at a CAGR of 5.3% during 2018–2025.

Figure 1: Global Orthopedic Prosthetics Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

The key factors bolstering the market growth are increasing incidence of trauma/accidental injuries, introduction of custom-made implant products, favorable reimbursement for orthopedic prosthetics, rise in prevalence of life-style related diseases and disorders, and growing focus on containment of healthcare costs and distribution.
Based on product type, lower limb is anticipated to lead the market during 2018–2025

Request Sample Brochure  : https://tinyurl.com/y7vso3qa

Lower limb segment is expected to hold maximum share in the market during the forecast period due to innovations and technological advancement in the field of healthcare. However, the highest growth rate is predicted to be exhibited by upper limb segment during the forecast period owing to surging adoption of upper limb orthopedic prosthetics among healthcare professionals and patients due to their characteristics, such as high stability and technological advanced properties. Additionally, wide availability of technically advanced orthopedic prosthetics and rising demand for custom-made orthopedic prosthetics are likely to push the growth of global orthopedic prosthetics market in the next 8 to 10 years.

Based on technology type, electric powered segment is anticipated to lead the market during 2018–2025
Electric powered technology segment is expected to hold maximum share in the market during the forecast period due to innovations, technological advancement and high stability in the field of medical devices. Hybrid prosthetics segment is predicted to exhibit a high growth rate during the forecast period owing to surging adoption of technology among healthcare professionals.

Based on end user type, prosthetic clinics segment dominates the market and is projected to grow at the highest rate during 2018–2025
The end-user segment includes, hospitals, prosthetic clinics, rehabilitation centers and others. Technological advancement in healthcare industry and increasing research & development activities are likely to drive the growth of this segment. Prosthetic devices have been playing a crucial role in the healthcare facilities, especially in hospitals and prosthetic clinics, owing to their various advantages, such as they are user friendly, stable, technological advanced and nearly restores the normal function of the missing body part. The healthcare practitioners are increasingly using technology platforms to serve the growing hospitals and patients’ needs.

Big players are investing a lot in research & development activities. The companies are focusing on product launches for keeping their leadership in global orthopedic prosthetics market. 

Figure 2: Global Orthopedic Prosthetics Market Revenue, by Region, 2017

Source: GMI Research

North America held the largest share in global orthopedic prosthetics market in 2017 owing to increased government and private funding on healthcare infrastructure, growth in medical tourism and technological awareness in healthcare. Asia-Pacific is predicted to be the third most attractive regional market in global orthopedic prosthetics market and is likely to show steady growth rate in the next few years.

Various notable players operating in global orthopedic prosthetics market include, Smith and Nephew plc, Biomet Inc., Johnson & Johnson, Fillauer LLC, Stryker Corp., Otto Bock HealthCare GmbH, Blatchford Ltd, Touch Bionics Inc., Hanger Inc., and The Ohio Willow Wood Co.

The global orthopedic prosthetics market has been segmented on the basis of product type, technology type, end user type and key geographies. Based on product type, the market comprises of upper limb, lower limb and others (sockets, fingers, etc). The technology type includes conventional, electric powered and hybrid prosthetics. The end user type includes hospitals, prosthetic clinics, rehabilitation centers & others (ASCs, normal clinics, etc.).

The research report “global orthopedic prosthetics market” provides in-depth analysis of the orthopedic prosthetics market, globally, based on product type, technology type, end user type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for orthopedic prosthetics market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is the orthopedic prosthetics market growing worldwide? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in global orthopedic prosthetics market?
4-    What are the various application areas and how they are poised to grow?

For Sample Pages & Detailed Report Description Click  @  https://www.gmiresearch.com/report/global-orthopedic-prosthetics-market-opportunities-forecast-by-product-type-technology-end-user-share-trends-insights.html

Table of Contents (TOC)

1.    Executive Summary

2.    Introduction      
2.1.    Study Objectives
2.2.    Market Definition
2.2.1.     Market Covered
2.2.2.    Geographical Coverage
2.2.3.    Study Years & Currency
2.3.    Market Stakeholders
2.4.    Key Questions this Study will Answer
2.5.    GMI Research’s Approach & Methodology
3.    Global Orthopedic Prosthetics Market – Overview
3.1.    Introduction         `
3.2.    Market Segmentation
3.3.    Pipeline Analysis
3.4.    Drivers
3.5.    Restraints
3.6.    Trends
4.    Global Orthopedic Prosthetics Market Revenue Forecast till 2025

5.    Global Orthopedic Prosthetics Market by Product Type Revenue Forecast till 2025 
5.1.    Upper Limb
5.2.    Lower Limb
5.3.    Others
6.    Global Orthopedic Prosthetics Market by Technology Type Revenue Forecast till 2025
6.1.    Conventional Technology
6.2.    Electric Powered Technology
6.3.    Hybrid Technology
7.    Global Orthopedic Prosthetics Market by End User Revenue Forecast till 2025  
7.1.    Hospitals
7.2.    Prosthetic Clinics
7.3.    Rehabilitation Centers
7.4.    Others
8.    Global Orthopedic Prosthetics Market by Geography Revenue Forecast till 2025

8.1.    North America Orthopedic Prosthetics Market Revenue Forecast till 2025
8.1.1.    North America Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.1.1.1.    Upper Limb
8.1.1.2.    Lower Limb
8.1.1.3.    Others
8.1.2.    North America Orthopedic Prosthetics Market by Technology Type
8.1.2.1.    Conventional Technology
8.1.2.2.    Electric Powered Technology
8.1.2.3.    Hybrid Technology
8.1.3.    North America Orthopedic Prosthetics Market by End User
8.1.3.1.    Hospitals
8.1.3.2.    Prosthetic Clinics
8.1.3.3.    Rehabilitation Centers
8.1.3.4.    Others

8.2.    Europe Orthopedic Prosthetics Market Revenue Forecast till 2025
8.2.1.    Europe Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.2.1.1.    Upper Limb
8.2.1.2.    Lower Limb
8.2.1.3.    Others
8.2.2.    Europe Orthopedic Prosthetics Market by Technology Type
8.2.2.1.    Conventional Technology
8.2.2.2.    Electric Powered Technology
8.2.2.3.    Hybrid Technology
8.2.3.    Europe Orthopedic Prosthetics Market by End User
8.2.3.1.    Hospitals
8.2.3.2.    Prosthetic Clinics
8.2.3.3.    Rehabilitation Centers
8.2.3.4.    Others
8.3.    Asia Pacific Orthopedic Prosthetics Market Revenue Forecast till 2025
8.3.1.    Asia-Pacific Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.3.1.1.    Upper Limb
8.3.1.2.    Lower Limb
8.3.1.3.    Others
8.3.2.    Asia-Pacific Orthopedic Prosthetics Market by Technology Type
8.3.2.1.    Conventional Technology
8.3.2.2.    Electric Powered Technology
8.3.2.3.    Hybrid Technology
8.3.3.    Asia-Pacific Orthopedic Prosthetics Market by End User
8.3.3.1.    Hospitals
8.3.3.2.    Prosthetic Clinics
8.3.3.3.    Rehabilitation Centers
8.3.3.4.    Others
8.4.    Rest of the World Orthopedic Prosthetics Market Revenue Forecast till 2025
8.4.1.    Rest of the World Orthopedic Prosthetics Market by Product Type (Option 1: 25% customization)
8.4.1.1.    Upper Limb
8.4.1.2.    Lower Limb
8.4.1.3.    Others
8.4.2.    Rest of the World Orthopedic Prosthetics Market by Technology Type
8.4.2.1.    Conventional Technology
8.4.2.2.    Electric Powered Technology
8.4.2.3.    Hybrid Technology
8.4.3.    Rest of the World Orthopedic Prosthetics Market by End User
8.4.3.1.    Hospitals
8.4.3.2.    Prosthetic Clinics
8.4.3.3.    Rehabilitation Centers
8.4.3.4.    Others

9.    Competitive Landscape  
9.1.    Industry Attractiveness
9.2.    Porter 5 Analysis
9.3.    Major players and their key strategies
9.4.    Company Share Analysis
10.    Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
10.1.    Smith and Nephew Plc
10.1.1.    Company Overview
10.1.2.    Financials
10.1.3.    Recent Developments
10.2.    Zimmer Biomet, Inc.
10.2.1.    Company Overview
10.2.2.    Financials
10.2.3.    Recent Developments
10.3.    Johnson & Johnson Inc
10.3.1.    Company Overview
10.3.2.    Financials
10.3.3.    Recent Developments
10.4.    Fillauer LLC
10.4.1.    Company Overview
10.4.2.    Financials
10.4.3.    Recent Developments
10.5.    Stryker Corp
10.5.1.    Company Overview
10.5.2.    Financials
10.5.3.    Recent Developments
10.6.    Otto bock HealthCare GmbH
10.6.1.    Company Overview
10.6.2.    Financials
10.6.3.    Recent Developments
10.7.    Blatchford Ltd
10.7.1.    Company Overview
10.7.2.    Financials
10.7.3.    Recent Developments
10.8.    Touch Bionics Inc
10.8.1.    Company Overview
10.8.2.    Financials
10.8.3.    Recent Developments
10.9.    Hanger, Inc
10.9.1.    Company Overview
10.9.2.    Financials
10.9.3.    Recent Developments
10.10.    The Ohio Willow Wood Co.
10.10.1.    Company Overview
10.10.2.    Financials
10.10.3.    Recent Developments
11.    About GMI Research

Buy Report @ https://tinyurl.com/y7vso3qa

Related Report :

Global Anti-Epileptic Drugs Market, By Spectrum Type (Narrow Spectrum and Broad Spectrum), By Drug (Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide) and Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

Global Anti-Epileptic Drugs Market Opportunities & Forecast (2018-2025)-GMI Research

Global Anti-Epileptic Drugs Market Opportunities & Forecast (2018-2025)-GMI Research

Global Anti-Epileptic Drugs Market, By Spectrum Type (Narrow Spectrum and Broad Spectrum), By Drug (Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide) and Geography – Opportunities & Forecast, 2018-2025

The global Anti-Epileptic Drugs market was valued at USD 3,323.7 million in 2017 and is projected to reach USD 4,458.1 million by 2025, growing at a CAGR of 3.8% during 2018–2025.

Figure 1: Global Anti-Epileptic Drugs Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

The antiepileptic drug can also be known as an anti-seizure drug, developed for the asymptomatic and idiopathic treatment of epilepsy and seizures. Antiepileptic drugs can also be used for the treatment of neuropathic pain. Causes of epilepsy seizures are not defined or undetermined. However major factors involved include brain injury, stroke, and substance use disorders. Treatment of epilepsy, antiepileptic drugs or medicines (AEDs) are prescribed, preference is made depending on the age of the patient, type of seizures to be treated, and which part of the brain is involved. Moreover, alcoholism, smoking, dietary habits, and rising geriatric population are the major factor driving the antiepileptic drugs market.

Request Sample Brochure  : https://tinyurl.com/y776x8ar

Based on Drugs, Valproic Acid (salt) is anticipated to lead the market during 2018–2025
The valporic Acid segment is expected to hold maximum share in the market during the forecast period due to effective drug structure and usage in most type of seizures. However, the highest growth rate is predicted to be exhibited by Lacosamide drug during the forecast period owing to surging adoption of Anti-Epileptic Drugs market among healthcare professionals and patients due to its homogenous structure. Additionally, the wide availability of technically advanced Anti-Epileptic Drugs diagnosis and treatment and rising demand for home-based Anti-Epileptic Drugs treatment are likely to push the growth of global Anti-Epileptic Drugs market in the forecast years.

Figure 2: Global Anti-Epileptic Drugs Market Revenue, by Region, 2017

Source: GMI Research

North America held the largest share in the global Anti-Epileptic Drugs market in 2017 owing to the growing social awareness, social acceptance, awareness among the population and government and private inclination on Anti-Epileptic Drugs issues. Rest of the World is predicted to be the attractive regional market in global Anti-Epileptic Drugs market and is likely to show the maximum growth in the next few years.

Various notable players operating in global Anti-Epileptic Drugs market include Abbott Laboratories, Cephalon, Inc, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi S.A, UCB Pharma Ltd, GlaxoSmithKline plc, Johnson & Johnson, Novartis, AG, Pfizer Inc among others.

The global Anti-Epileptic Drugs market has been segmented on the basis of spectrum type, drug type, and key geographies. Based on spectrum type, the market comprises of Narrow Spectrum and Broad Spectrum. The drug type includes Phenytoin, Phenobarbital, Carbamazepine, Oxcarbazepine, Gabapentin, Pregabalin, Lacosamide, Vigabatrin, Valproic Acid, Lamotrigine, Topiramate, Zonisamide, Levetiracetam, Clonazepam, Rufinamide

The research report “global Anti-Epileptic Drugs market” provides in-depth analysis of the Anti-Epileptic Drugs market, globally, based on spectrum type, drug type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Anti-Epileptic Drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is the Anti-Epileptic Drugs market growing worldwide? What will be the growth trend in the future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in global Anti-Epileptic Drugs market?
4-    What are the various application areas and how they are poised to grow?

For Sample Pages & Detailed Report Description Click  @   https://www.gmiresearch.com/report/global-anti-epileptic-drugs-market-opportunities-forecast-by-spectrum-type-share-trends-industry-report.html

Table of Contents (TOC)

1.    Executive Summary

2.    Introduction    
2.1.    Study Objectives
2.2.    Market Definition
2.2.1.     Market Covered
2.2.2.    Geographical Coverage
2.2.3.    Study Years & Currency
2.3.    Market Stakeholders
2.4.    Key Questions this Study will Answer
2.5.    GMI Research’s Approach & Methodology

3.    Global Anti-Epileptic Drugs Market – Overview   
3.1.    Introduction         `
3.2.    Market Segmentation
3.3.    Pipeline Analysis
3.4.    Drivers
3.5.    Restraints
3.6.    Trends
4.    Global Anti-Epileptic Drugs Market Revenue Forecast till 2025

5.    Global Anti-Epileptic Drugs Market by Spectrum Revenue Forecast till 2025  
5.1.    Narrow Spectrum
5.2.    Broad Spectrum
6.    Global Anti-Epileptic Drugs Market by Drug Revenue Forecast till 2025
6.1.    Phenytoin
6.2.    Phenobarbital
6.3.    Carbamazepine
6.4.    Oxcarbazepine
6.5.    Gabapentin
6.6.    Pregabalin
6.7.    Lacosamide
6.8.    Vigabatrin
6.9.    Valproic Acid
6.10.    Lamotrigine
6.11.    Topiramate
6.12.    Zonisamide
6.13.    Levetiracetam
6.14.    Clonazepam
6.15.    Rufinamide
7.    Global Anti-Epileptic Drugs Market by Geography Revenue Forecast till 2025

7.1.    North America Anti-Epileptic Drugs Market Revenue Forecast till 2025 (Option 1: 25% customization)
7.1.1.    North America Anti-Epileptic Drugs Market Revenue by Spectrum Forecast till 2025
7.1.1.1.    Narrow Spectrum
7.1.1.2.    Broad Spectrum

7.1.2.    North America Anti-Epileptic Drugs Market by drug Revenue Forecast till 2025
7.1.2.1.    Phenytoin
7.1.2.2.    Phenobarbital
7.1.2.3.    Carbamazepine
7.1.2.4.    Oxcarbazepine
7.1.2.5.    Gabapentin
7.1.2.6.    Pregabalin
7.1.2.7.    Lacosamide
7.1.2.8.    Vigabatrin
7.1.2.9.    Valproic Acid
7.1.2.10.    Lamotrigine
7.1.2.11.    Topiramate
7.1.2.12.    Zonisamide
7.1.2.13.    Levetiracetam
7.1.2.14.    Clonazepam
7.1.2.15.    Rufinamide.

7.2.    Europe Anti-Epileptic Drugs Market Revenue Forecast till 2025
7.2.1.    Europe Anti-Epileptic Drugs Market by Spectrum Revenue Forecast till 2025 (Option 2: 25% customization)
7.2.1.1.    Narrow Spectrum
7.2.1.2.    Broad Spectrum

7.2.2.    Europe Anti-Epileptic Drugs Market by Drug Revenue Forecast till 2025
7.2.2.1.    Phenytoin
7.2.2.2.    Phenobarbital
7.2.2.3.    Carbamazepine
7.2.2.4.    Oxcarbazepine
7.2.2.5.    Gabapentin
7.2.2.6.    Pregabalin
7.2.2.7.    Lacosamide
7.2.2.8.    Vigabatrin
7.2.2.9.    Valproic Acid
7.2.2.10.    Lamotrigine
7.2.2.11.    Topiramate
7.2.2.12.    Zonisamide
7.2.2.13.    Levetiracetam
7.2.2.14.    Clonazepam
7.2.2.15.    Rufinamide.

7.3.    Asia-Pacific Anti-Epileptic Drugs Market Revenue Forecast till 2025
7.3.1.    Asia-Pacific Anti-Epileptic Drugs Market by Spectrum Revenue Forecast till 2025 (Option 3: 25% customization)
7.3.1.1.    Narrow Spectrum
7.3.1.2.    Broad Spectrum

7.3.2.    Asia-Pacific Anti-Epileptic Drugs Market by Drug Revenue Forecast till 2025
7.3.2.1.    Phenytoin
7.3.2.2.    Phenobarbital
7.3.2.3.    Carbamazepine
7.3.2.4.    Oxcarbazepine
7.3.2.5.    Gabapentin
7.3.2.6.    Pregabalin
7.3.2.7.    Lacosamide
7.3.2.8.    Vigabatrin
7.3.2.9.    Valproic Acid
7.3.2.10.    Lamotrigine
7.3.2.11.    Topiramate
7.3.2.12.    Zonisamide
7.3.2.13.    Levetiracetam
7.3.2.14.    Clonazepam
7.3.2.15.    Rufinamide.

7.4.    Rest of the World Anti-Epileptic Drugs Market Revenue Forecast till 2025
7.4.1.    Rest of the World Anti-Epileptic Drugs Market by Spectrum Revenue Forecast till 2025 (Option 4: 25% customization)
7.4.1.1.    Narrow Spectrum
7.4.1.2.    Broad Spectrum

7.4.2.    Rest of the World Anti-Epileptic Drugs Market by Drug Revenue Forecast till 2025
7.4.2.1.    Phenytoin
7.4.2.2.    Phenobarbital
7.4.2.3.    Carbamazepine
7.4.2.4.    Oxcarbazepine
7.4.2.5.    Gabapentin
7.4.2.6.    Pregabalin
7.4.2.7.    Lacosamide
7.4.2.8.    Vigabatrin
7.4.2.9.    Valproic Acid
7.4.2.10.    Lamotrigine
7.4.2.11.    Topiramate
7.4.2.12.    Zonisamide
7.4.2.13.    Levetiracetam
7.4.2.14.    Clonazepam
7.4.2.15.    Rufinamide.

8.    Competitive Landscape        
8.1.    Industry Attractiveness
8.2.    Porter 5 Analysis
8.3.    Major players and their key strategies
8.4.    Company Share Analysis

9.    Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
9.1.    Abbott Laboratories
9.1.1.    Company Overview
9.1.2.    Financials
9.1.3.    Recent Developments
9.2.    Cephalon, Inc
9.2.1.    Company Overview
9.2.2.    Financials
9.2.3.    Recent Developments
9.3.    Sunovion Pharmaceuticals
9.3.1.    Company Overview
9.3.2.    Financials
9.3.3.    Recent Developments
9.4.    Valeant Pharmaceuticals International
9.4.1.    Company Overview
9.4.2.    Financials
9.4.3.    Recent Developments
9.5.    Sanofi S.A
9.5.1.    Company Overview
9.5.2.    Financials
9.5.3.    Recent Developments
9.6.    UCB Pharma Ltd
9.6.1.    Company Overview
9.6.2.    Financials
9.6.3.    Recent Developments
9.7.    GlaxoSmithKline plc
9.7.1.    Company Overview
9.7.2.    Financials
9.7.3.    Recent Developments
9.8.    Johnson & Johnson
9.8.1.    Company Overview
9.8.2.    Financials
9.8.3.    Recent Developments
9.9.    Novartis AG
9.9.1.    Company Overview
9.9.2.    Financials
9.9.3.    Recent Developments
9.10.    Pfizer Inc
9.10.1.    Company Overview
9.10.2.    Financials
9.10.3.    Recent Developments

10.    About GMI Research

Buy Report @ https://tinyurl.com/y776x8ar

Related Report :

Global Drugs of Abuse Testing Market by Product Type (Instruments and Consumables), By Drug Type (Psychostimulants, Narcotic, Hallucinogens, Sedatives and Others), By Technique Type (Immunoassay, Chromatography and Rapid Testing), By End-User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Government and Private Departments and Others) and by Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

Global Telemedicine Market Opportunities & Forecast (2018-2025)-GMI Research

Global Telemedicine Market Opportunities & Forecast (2018-2025)-GMI Research

Global Telemedicine Market by Component Type (Hardware, Software, Services and Telecom & Networking), By Speciality (Teleradiology, Telecardiology, Telepsychiatry and Others (Telepathology and Teledermatology)) End-Users (Telehospitals & Teleclinics and Telehome) and by Geography – Opportunities & Forecast, 2018-2025

Telemedicine is a technology which is used for real-time communication between patient and healthcare service provider via electronic audio-video channels. The deployment of telemedicine has prominently changed the healthcare paradigm, which is why various technological innovation in the field of medical device and services are taking place. For instance, in January 2018, American Well and Philips partnered to introduce virtual care services in near future. Further, the growing need for the home-based health services and .regional governments initiatives and policies to improve healthcare services are expected to increase the penetration of telemedicine industry, specifically in the developing regions in coming 5-6 years.

Request Sample Pages : https://tinyurl.com/yauuvuyt

The propelling geriatric population coupled with rising prevalence of chronic diseases, the dearth of healthcare professionals worldwide, improvements in telecommunication infrastructure, and need for affordable treatment options and procedures due to increasing healthcare costs are some of the factors that are expected to fuel the growth of telemedicine market in the coming years. In addition, exponential growth and rise in the development of the telecommunication sector coupled with high disposable income are presumed to account for the increase in healthcare expenditure over the forecast period. Need to connect and aid patients in the remote areas is presumed to further boost the market growth over the forecast period. Massive infrastructure cost and initial investment related to telemedicine industry are expected to hinder the industry growth over the forecast period. Data security concerns about the leak of sensitive patient’s health information are expected to have an adverse impact on the market growth. Some of the key factors hindering the growth of telemedicine market include lack of skilled and trained professionals in the remote areas, privacy and security concern and limited availability of telecommunications bandwidth.

Various notable players operating in the market, include McKesson Corporation, Philips Healthcare, GE Healthcare Ltd, IBM, Cerner Corporation, AMD Global Telemedicine, Inc, Cisco Systems, Inc, Honeywell Life Care Solutions, Medtronic Plc, Aerotel Medical Systems. among others. Most of the company are focusing on R&D activities, which has helped companies to launch technologically advanced clinical services.

The global telemedicine market has been segmented on the basis of component type, speciality, end-use, and key geographies. Based on the component type, the market comprises hardware, software, services and telecom & networking. The research report “global telemedicine market” provides in-depth analysis of global telemedicine market based on component type, speciality, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global telemedicine market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is telemedicine market growing? What will be the growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the telemedicine market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation
•    By Component Type 
•    Hardware
o    Medical Devices
o    Monitors
o    Others
•    Software
o    Integrated
o    Others
•    Services
o    Store and Forward
o    Telenursing
o    Teleconsulting
o    Others (Tele monitoring etc)
•    Telecom and Networking
•    By Speciality 
•    Teleradiology
•    Telecardiology
•    Telepsychiatry
•    Others (Telepathology and Teledermatology)
•    By End User  
•    Telehospitals and teleclinics
•    Telehome
By Geography
•    North America 
As a part of customization
o    By Component type
o    By Speciality
o    By End users
o    US
o    Canada
o    Mexico
•    Europe
As a part of customization
o    By Component type
o    By Speciality
o    By End users
o    UK
o    Germany
o    Spain
o    Rest of Europe
•    Asia-Pacific
As a part of customization
o    By Component type
o    By Speciality
o    By End users
o    China
o    Australia
o    India
o    Rest of APAC
•    ROW
As a part of customization
o    By Component type
o    By Speciality
o    By End users
o    Brazil
o    South Africa
o    GCC countries
o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    McKesson Corporation
•    Philips Healthcare
•    GE Healthcare Ltd.
•    IBM
•    Cerner Corporation
•    AMD Global Telemedicine, Inc
•    Cisco System, Inc
•    Honeywell Life Care Solutions
•    Medtronic Plc
•    Aerotel Medical System

*Other prominent players in the market which can be profiled as a part of customization:
Siemens Healthcare
International Business Machines Corp
Roche
Verizon Communications Inc
Cybernet Medical Corp

For Sample Pages & Detailed Report Description Click  @ https://www.gmiresearch.com/report/global-tele-medicine-market-component-hardware-software-services-telecom-networking-speciality-opportunities-forecast-share.html

Table of Contents (TOC)

  • Executive Summary

 Introduction  

  • Study Objectives
  • Market Definition
  •  Market Covered
  • Geographical Coverage
  • Study Years & Currency
  • Market Stakeholders
  • Key Questions this Study will Answer
  • GMI Research’s Approach & Methodology
  • Global Telemedicine Market- Overview       
  • Introduction         `
  • Market Segmentation
  • Value Chain Analysis
  • Drivers
  • Restraints
  • Trends
  • Global Telemedicine Market Revenue Forecast till 2025
  •  Global Telemedicine Market by Component Type Revenue Forecast till 2025      
  • Hardware
  • Medical Devices
  • Monitors
  • Others
  • Software
  • Integrated
  • Others
  • Services
  • Store and Forward
  • Telenursing
  • Others (Tele monitoring etc)
  • Telecom and Networking
  • Global Telemedicine Market by Speciality Revenue Forecast till 2025         
  • Teleradiology
  • Telecardiology
  • Telepsychiatry
  • Others (Telepathology and Teledermatology)
  • Global Telemedicine Market by End User Revenue Forecast till 2025     
  • Telehospitals and teleclinics
  • Telehome
  • Global Telemedicine Market by Geography Revenue Forecast till 2025
  • North America Telemedicine Market Revenue Forecast till 2025       
  • North America Telemedicine Market by Component Type Revenue Forecast till 2025  (Option 1: 25% customization)
  • Hardware
  • Medical Devices
  • Monitors
  • Others
  • Software
  • Integrated
  • Others
  • Services
  • Store and Forward
  • Telenursing
  • Others (Tele monitoring etc)
  • Telecom and Networking
  • North America Telemedicine Market by Speciality Revenue Forecast till 2025
  • Teleradiology
  • Telecardiology
  • Telepsychiatry
  • Others (Telepathology and Teledermatology)
  • North America Telemedicine Market by End User Revenue Forecast till 2025
  • Telehospitals and teleclinics
  • Telehome
  •  Europe Telemedicine Market Revenue Forecast till 2025    
  • Europe Telemedicine Market by Component Type (Option 2: 25% customization)
  • Hardware
  • Medical Devices
  • Monitors
  • Others
  • Software
  • Integrated
  • Others
  • Services
  • Store and Forward
  • Telenursing
  • Others (Tele monitoring etc)
  • Telecom and Networking
  • Europe Telemedicine Market by Speciality Revenue Forecast till 2025
  • Teleradiology
  • Telecardiology
  • Telepsychiatry
  • Others (Telepathology and Teledermatology)
  • Europe Telemedicine Market by End User Revenue Forecast till 2025
  • Telehospitals and teleclinics
  • Telehome
  • Asia-Pacific Telemedicine Market Revenue Forecast till 2025       
  • Asia-Pacific Telemedicine Market by Component Type (Option 1: 25% customization)
  • Hardware
  • Medical Devices
  • Monitors
  • Others
  • Software
  • Integrated
  • Others
  • Services
  • Store and Forward
  • Telenursing
  • Others (Tele monitoring etc)
  • Telecom and Networking
  • Asia-Pacific Telemedicine Market by Speciality Revenue Forecast till 2025
  • Teleradiology
  • Telecardiology
  • Telepsychiatry
  • Others (Telepathology and Teledermatology)
  • Asia-Pacific Telemedicine Market by End User Revenue Forecast till 2025
  • Telehospitals and teleclinics
  • Telehome
  • Rest of the World Telemedicine Market Revenue Forecast till 2025    
  • Rest of the World Telemedicine Market by Component Type (Option 4: 25% customization)
  • Hardware
  • Medical Devices
  • Monitors
  • Others
  • Software
  • Integrated
  • Others
  • Services
  • Store and Forward
  • Telenursing
  • Others (Tele monitoring etc)
  • Telecom and Networking
  • Rest of the World Telemedicine Market by Speciality Revenue Forecast till 2025
  • Teleradiology
  • Telecardiology
  • Telepsychiatry
  • Others (Telepathology and Teledermatology)
  • Rest of the World Telemedicine Market by End User Revenue Forecast till 2025
  • Telehospitals and teleclinics
  • Telehome
  • Competitive Landscape   
  • Porter 5 Analysis
  • Major players and their key strategies
  • Company Share Analysis
  •  Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
  • McKesson Corporation
  • Company Overview
  • Financials
  • Recent Developments
  • Philips Healthcare
  • Company Overview
  • Financials
  • Recent Developments
  • GE Healthcare Ltd.
  • Company Overview
  • Financials
  • Recent Developments
  • IBM
  • Company Overview
  • Financials
  • Recent Developments
  • Cerner Corporation
  • Company Overview
  • Financials
  • Recent Developments
  • AMD Global Telemedicine, Inc
  • Company Overview
  • Financials
  • Recent Developments
  • Cisco Systems, Inc
  • Company Overview
  • Financials
  • Recent Developments
  • Honeywell Life Care Solutions
  • Company Overview
  • Financials
  • Recent Developments
  • Medtronic Plc
  • Company Overview
  • Financials
  • Recent Developments
  • Aerotel Medical Systems
  • Company Overview
  • Financials
  • Recent Developments
  • About GMI Research

Buy Report @ https://tinyurl.com/yauuvuyt

Global Patient Positioning Device Market by Product Type (Tables, Chairs, Accessories and Others), By Application (Surgery, Diagnostics and Others) End-Users (Hospitals, Clinics and Others (Ascs and Diagnostic Laboratories) and by Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com